Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
PHASE2
The primary objective of this study is to assess the efficacy of Glycopyrro...
A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients Who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)
N/A
Patients with chronic obstructive pulmonary disease (COPD) have elevated ri...
NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
N/A
Observational prospective study to evaluate serum NT-proBNP levels in a pop...
Status
Unknown
Location
INRCA Hospital
Start Date
2022-06-28
Trial ID
NCT06317428
A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).
PHASE3
This study will investigate the effect of Budesonide, Glycopyrronium, and F...